Pfizer Inc.

Pharmaceuticals & BiotechnologyFounded 1849

Market Data Current As Of: September 19, 2026

Related Competitor Intelligence

Compare market positioning with top industry peers

Competitor

Explore Pfizer

Core profile pages, annual revenue records, and related research hubs for this company.

Pfizer Inc.

Pharmaceuticals & BiotechnologyFounded 1849

Reviewed by Swet Parvadiya

Last reviewed: September 19, 2026

Market Data Current As Of: September 19, 2026

Financial Performance

Pfizer Revenue & Financials

Name: Pfizer Inc. Annual Revenue History
Creator: CorpDigest
License: https://corpdigest.com/terms

Revenue

$62.58B

Market Cap

$156.8B

Net Income

$7.8B

Employees

88,000

Financial Analysis

Pfizer's financial narrative is a massive, terrifying story of a historic 'COVID Boom' followed by a highly painful, multi-billion dollar 'COVID Hangover'. During the pandemic, their revenue absolutely exploded to over $100 billion as the world desperately bought their vaccine and antiviral pill (Paxlovid). However, as the pandemic ended, revenue instantly crashed. Their current financial strategy is utilizing the massive mountain of cash they hoarded during the pandemic to execute highly aggressive, multi-billion dollar acquisitions (like buying Seagen for $43 billion) to secure cancer treatments before their legacy drug patents expire.

Revenue Trend Analysis

YoY Change

-1.6%

5-Year CAGR

+8.5%

Peak Year

2022

Trend

Mostly Growing

Pfizer Inc. has reported revenue across 6 fiscal years, compounding at +8.5% annually over 5 years. The most recent year saw a 1.6% decline versus the prior year. Revenue peaked in 2022 at $101.2B. Out of 5 reported periods, 3 showed growth and 2 showed a decline.

Annual Revenue History

Fiscal Year	Revenue	Net Income	YoY Change
FY2025	$62.6B	$7.8B	-1.6%
FY2024	$63.6B	$8.0B	+6.8%
FY2023	$59.6B	$2.1B	-41.1%
FY2022	$101.2B	$31.4B	+24.5%
FY2021	$81.3B	$22.0B	+95.2%
FY2020	$41.7B	$9.2B	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

Click any row to see year details.

Related Companies

Eli Lilly and Company Novartis AG Novo Nordisk A/S Bausch Health Companies Inc.

Compare Pfizer Inc. Revenue With Competitors

Pfizer Inc. vs Eli Lilly and Company →Pfizer Inc. vs Novartis AG →Pfizer Inc. vs Novo Nordisk A/S →Pfizer Inc. vs Bausch Health Companies Inc. →

Pfizer Revenue and Financial FAQ

What was Pfizer Inc.'s reported annual revenue for FY2025?

Pfizer Inc. reported approximately $63.6B in fiscal year 2025 with a team of 88,000 employees worldwide.

How does Pfizer Inc. allocate capital and manage operating margins?

Pfizer Inc. strategically balances reinvestment into core R&D with operational cost discipline, focusing on workflow automation to expand operating margins in 2026.

What is the long-term financial outlook for Pfizer Inc. in Pharmaceuticals & Biotechnology?

Financial performance in Pharmaceuticals & Biotechnology is driven by steady cash generation and pricing power, enabling Pfizer Inc. to reinvest in high-return strategic initiatives.

Cite or embed this data

Using these figures? Please credit CorpDigest with a link.

Cite this page

CorpDigest. "Pfizer Inc. Revenue & Financials." CorpDigest, https://corpdigest.com/company/pfizer/financials.

Embed this data

<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Pfizer Inc. reported $63B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/pfizer/financials" target="_blank" rel="noopener">CorpDigest — Pfizer Inc. financials</a></div>

Related Competitor Intelligence

Compare market positioning with top industry peers

Competitor

Eli Lilly and Company

View Competitor Intelligence

Competitor

Novartis AG

View Competitor Intelligence

Competitor

Novo Nordisk A/S

View Competitor Intelligence

Competitor

Bausch Health Companies Inc.

View Competitor Intelligence

Competitor

Johnson And Johnson

View Competitor Intelligence

Competitor

Merck

View Competitor Intelligence

Explore Pfizer

Core profile pages, annual revenue records, and related research hubs for this company.

Financial Analysis

Fiscal Year

Revenue

Net Income

YoY Change

FY2025

$62.6B

$7.8B

-1.6%

FY2024

$63.6B

$8.0B

+6.8%

FY2023

$59.6B

$2.1B

-41.1%

FY2022

$101.2B

$31.4B

+24.5%

FY2021

$81.3B

$22.0B

+95.2%

FY2020

$41.7B

$9.2B

—

Pfizer Revenue and Financial FAQ

What was Pfizer Inc.'s reported annual revenue for FY2025?

Pfizer Inc. reported approximately $63.6B in fiscal year 2025 with a team of 88,000 employees worldwide.

How does Pfizer Inc. allocate capital and manage operating margins?

Pfizer Inc. strategically balances reinvestment into core R&D with operational cost discipline, focusing on workflow automation to expand operating margins in 2026.

What is the long-term financial outlook for Pfizer Inc. in Pharmaceuticals & Biotechnology?

Financial performance in Pharmaceuticals & Biotechnology is driven by steady cash generation and pricing power, enabling Pfizer Inc. to reinvest in high-return strategic initiatives.

Cite or embed this data

Using these figures? Please credit CorpDigest with a link.

Cite this page

CorpDigest. "Pfizer Inc. Revenue & Financials." CorpDigest, https://corpdigest.com/company/pfizer/financials.

Embed this data

<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Pfizer Inc. reported $63B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/pfizer/financials" target="_blank" rel="noopener">CorpDigest — Pfizer Inc. financials</a></div>